These observations were unexpected and counterintuitive since PD-1 serves as a checkpoint inhibitory molecule to tone down TCR-mediated responses and T cell autoimmunity [5, 29], and we have observed an increase in the expression of PD-1 in the disease tissue with rampant T cell activation. The gene discussed is PDCD1; the disease is Autoimmunity.